FQ
AMAG

First Quadrant’s AMAG Pharmaceuticals AMAG Stock Holding History

First Quadrant’s Portfolio AMAG Stock Details AMAG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-3,587
Closed -$46K – 772
2019
Q1 		$46K Sell
3,587
-5,667
-61% -$84.4K ﹤0.01% 643
2018
Q4 		$141K Buy
+9,254
New +$176K 0.01% 592
2014
Q1 		– Sell
-7,000
Closed -$170K – 798
2013
Q4 		$170K Hold
7,000
– – ﹤0.01% 574
2013
Q3 		$150K Hold
7,000
– – ﹤0.01% 573
2013
Q2 		$156K Buy
+7,000
New +$154K ﹤0.01% 560

Other funds holding AMAG

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

First Quadrant's AMAG Position: Q2 2019 in Review

First Quadrant sold out of AMAG Pharmaceuticals (AMAG) in Q2 2019, closing a stake of 3,587 shares — an estimated $46K sold.

First Quadrant first reported a position in AMAG in Q2 2013 and held it in 5 quarters. The position peaked at $170K in Q4 2013. 170 funds tracked by Wall St. Rank hold AMAG as of Q2 2019.

  • First Quadrant reported no remaining AMAG Pharmaceuticals position as of Q2 2019 after selling out during the quarter.
  • First Quadrant sold 3,587 AMAG Pharmaceuticals shares in Q2 2019, an estimated $46K.
  • First Quadrant first reported a position in AMAG Pharmaceuticals in Q2 2013 and held it in 5 quarters.
  • First Quadrant's AMAG Pharmaceuticals position peaked at $170K in Q4 2013.
  • 170 funds tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q2 2019.

Based on First Quadrant's 13F filing for Q2 2019, filed 24 Jul 2019.